The Anticancer Mechanism of the Ribonucleotide Reductase Inhibiting Drug COH29 Involves Suppression of DNA Repair

Bingsen Zhou (Contributor)
Keqiang Zhang (Contributor)
F. Un (Contributor)
Shuya Hu (Contributor)
Jun Wu (Contributor)
Yan Wang (Contributor)
Xiyong Liu (Contributor)
Hongzhi Li (Contributor)
Zheng Liu (Contributor)
Leila Su (Contributor)
Yun Yen (Contributor)

資料集

1 文章

1結果

2015
The novel ribonucleotide reductase inhibitor COH29 inhibits DNA repair in vitros
Chen, M. C., Zhou, B., Zhang, K., Yuan, Y. C., Un, F., Hu, S., Chou, C. M., Chen, C. H., Wu, J., Wang, Y., Liu, X., Smith, D. L., Li, H., Liu, Z., Warden, C. D., Su, L., Malkas, L. H., Chung, Y. M., Hu, M. C. T. & Yen, Y., 6月 1 2015, 於: Molecular Pharmacology. 87, 6, p. 996-1005 10 p.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取
21 引文斯高帕斯（Scopus）